Cashing in your chips: speculation on the future of diagnostic laboratories in the era of DNA chips -- 50 (2): 111 -- Journal of Medical Microbiology

This article discusses microfluidic and lab-on-a-chip technologies for rapid bacterial detection and nucleic acid analysis in clinical diagnostics. The paper reviews integrated systems that combine sample preparation, nucleic acid extraction, amplification, and detection on miniaturized devices. Key technologies examined include PCR and isothermal amplification methods integrated with microfluidic platforms, particularly for detecting bacterial pathogens from clinical specimens. The authors describe devices incorporating cell lysis, protein removal, nucleic acid extraction, and target-specific detection using methods like dot-blot hybridization and probe capture. The article emphasizes the advantages of these integrated systems for point-of-care diagnostics, including reduced reagent volumes, faster processing times, and automated workflows. Various amplification strategies (thermal and isothermal cycling) and detection approaches are evaluated for their effectiveness in identifying bacterial targets. The work highlights challenges in maintaining assay sensitivity and specificity while miniaturizing complex analytical procedures, and discusses the potential clinical applications of these technologies for rapid bacterial identification and antimicrobial susceptibility assessment in diagnostic laboratories.

Key findings

• Microfluidic devices integrating cell lysis, nucleic acid extraction, amplification, and detection enable rapid bacterial pathogen identification from clinical specimens
• Both thermal cycling PCR and isothermal amplification methods can be effectively incorporated into miniaturized lab-on-chip platforms
• Automated microfluidic systems reduce reagent consumption and processing time while maintaining analytical sensitivity and specificity for bacterial detection
• Integrated detection methods including probe capture and hybridization techniques demonstrate target-specific identification of bacterial nucleic acids on microfluidic platforms